- ILMN has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $264.5 million.
- ILMN has traded 12,505 shares today.
- ILMN is trading at a new lifetime high.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in ILMN with the Ticky from Trade-Ideas. See the FREE profile for ILMN NOW at Trade-Ideas More details on ILMN: Illumina, Inc. provides sequencing and array-based solutions for genetic analysis in North America, Europe, Latin America, the Asia-Pacific, the Middle East, and South Africa. ILMN has a PE ratio of 75. Currently there are 12 analysts that rate Illumina a buy, no analysts rate it a sell, and 6 rate it a hold. The average volume for Illumina has been 1.2 million shares per day over the past 30 days. Illumina has a market cap of $31.0 billion and is part of the health care sector and drugs industry. The stock has a beta of 0.30 and a short float of 2.5% with 3.01 days to cover. Shares are up 16.7% year-to-date as of the close of trading on Thursday. EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.